[CLDX] QoQ Quarter Result on 30-Sep-2012 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
02-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -9.10%
YoY- -27.65%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 97 2,414 3,647 3,113 2,009 2,433 2,434 -88.35%
PBT -19,016 -17,332 -16,807 -15,027 -13,362 -13,083 -12,294 33.78%
Tax -161 -379 -94 -105 -252 -410 268 -
NP -19,016 -17,332 -16,807 -15,027 -13,773 -13,516 -12,732 30.69%
Tax Rate - - - - - - - -
Total Cost 19,113 19,746 20,454 18,140 15,782 15,949 15,166 16.68%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin -19,604.12 -717.98 -460.84 -482.72 -685.56 -555.53 -523.09 1022.37%
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
EPS -3.53 -3.51 -4.03 -3.79 -3.52 -4.04 -3.81 -4.96%
EPS Diluted -3.53 -3.51 -4.03 -3.79 -3.52 -4.04 -3.81 -4.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.